Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


August 30, 2015 12:21 AM ET

Capital Markets

Company Overview of Perseus-Soros Biopharmaceutical Fund, L.P.

Company Overview

Perseus-Soros Biopharmaceutical Fund, L.P. specializes in equity investments in private and public life science companies developing biopharmaceutical products. The fund also invests in companies that are developing technologies to address bottlenecks in the drug discovery process. It typically invests between $10 million and $50 million, contingent upon the portfolio company's stage of development.

888 Seventh Avenue

12th Floor

New York, NY 10106

United States

Founded in 1999

Phone:

212-651-6380

Fax:

212-651-6379

Key Executives for Perseus-Soros Biopharmaceutical Fund, L.P.

Founder and Senior Advisor
Age: 60
Managing Partner
Age: 52
Managing Partner and Managing Director
Age: 50
Compensation as of Fiscal Year 2015.

Similar Private Companies By Industry

Company Name Region
Coburn & Meredith Inc. United States
DragonVenture, Inc., Advisory Arm United States
Diaz & Altschul Capital, LLC United States
Transforma Acquisition Group, Inc. United States
Norris & Associates LLC United States

Recent Private Companies Transactions

Type
Date
Target
Merger/Acquisition
June 5, 2015
Advion, Inc.
Merger/Acquisition
September 28, 2014
Ambit Biosciences Corporation
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Perseus-Soros Biopharmaceutical Fund, L.P., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.